Member Login
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (NYSE: BHC)
    3. /

NYSE:BHC (Bausch Health Companies Inc.)

About BHC

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (NYSE: BHC) Latest News

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Inc. a Soaring Rocket or a Hot Air Balloon?

    | Benjamin Sinclair

    Valeant Pharmaceuticals Inc. (TSX:VRX)(NYSE:VRX) has been a big win for its shareholders. Just how long can the good times last?

    Read more »

    Investing

    Should You Buy Valeant Pharmaceuticals Intl Inc. on the Salix Pharmaceuticals, Ltd. Acquisition News?

    | Jacob Donnelly

    I would hold for a dip on Valeant Pharmaceuticals Intl. Inc. (TSX:VRX)(NYSE:VRX) before buying on its recent acquisition news.

    Read more »

    Investing

    Is Valeant Pharmaceuticals Intl Inc a $250 Stock?

    | Leia Klingel

    Barclays analysts see Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) as an overlooked growth story. Is now the time to buy?

    Read more »

    The Motley Fool
    Investing

    4 Easy Ways to Invest in This Upcoming $1.2 Trillion Opportunity

    | Nelson Smith

    There's a common theme of why now's a good time to buy Loblaw Companies Limited (TSX:L), Extenticare Inc. (TSX:EXE), Chartwell…

    Read more »

    Investing

    (Review) These Stocks Have Hit 52-Week Highs: Should You Buy, Sell, or Hold?

    | Karen Thomas, MSc, CFA

    CGI Group Inc. (TSX:GIB.A)(NYSE:GIB) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have both hit 52-week highs. Here’s what to consider.

    Read more »

    Investing

    Will Pfizer Inc. Look to Buy Valeant Pharmaceuticals Intl Inc.?

    | Jacob Donnelly

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is the right size for Pfizer Inc. (NYSE:PFE), but Valeant might actually turn out to…

    Read more »

    Investing

    Invest in China With Valeant Pharmaceutical Intl Inc.

    | Jacob Donnelly

    China's middle class is growing, expanding the market for Valeant Pharmaceuticals International Inc.'s (TSX:VRX)(NYSE:VRX) products.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceutical International Inc. Changes Strategy; Is Now the Time to Buy?

    | Jacob Donnelly

    Valeant Pharmaceutical International Inc. (TSX:VRX)(NYSE:VRX) is changing strategies and avoiding acquisition. Does that make it a buy?

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceutical International Inc. Lost its Bid for Allergan, Inc; Now What?

    | Jacob Donnelly

    Valeant Pharmaceutical International Inc. (TSX:VRX)(NYSE:VRX) failed to buy Allergan, Inc. (NYSE:AGN), but I still think it is worth adding to…

    Read more »

    The Motley Fool
    Investing

    Should You Follow Billionaire Bill Ackman and Bet on Valeant Pharmaceuticals International Inc.?

    | Benjamin Sinclair

    Valeant Pharmaceuticals International Inc. (TSX:VRX)(NYSE:VRX) has achieved fantastic returns thus far. Will this continue?

    Read more »

    The Motley Fool
    Investing

    The Argument For and Against Valeant Pharmaceutical International Inc.’s Growth Strategy

    | Jacob Donnelly

    Valeant Pharmaceuticals International Inc. (TSX:VRX)(NYSE:VRX) invests little money in R&D and a lot in acquisitions. Is that good?

    Read more »

    The Motley Fool
    Investing

    Making Sense of the Valeant Pharmaceuticals International Inc. and Allergan, Inc. Acquisition Talks

    | Jacob Donnelly

    There's a big mess going on between Valeant Pharmaceuticals International Inc. (TSX:VRX)(NYSE:VRX) and Allergan, Inc. (NYSE:AGN). Dig deeper and you…

    Read more »